CBER regulates the collection of blood and blood components used for transfusion or for the manufacture of pharmaceuticals derived from blood and blood components. FDA has strengthened the safeguards that protect patients from unsuitable blood and blood products and has increased its oversight of the blood industry.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/30NFqIi
No comments:
Post a Comment